Acceptability of HIV Pre-Exposure Prophylaxis (PrEP) and Implementation Challenges Among Men Who Have Sex with Men in India: A Qualitative Investigation

AIDS Patient Care and STDs
Venkatesan ChakrapaniShalini Bharat

Abstract

This qualitative study explored the acceptability of HIV pre-exposure prophylaxis (PrEP) among MSM in India, and identified facilitators and barriers to future PrEP uptake. In 2014, we conducted 10 focus groups (n=61) among a purposive sample of diverse MSM recruited through community-based organizations in Chennai and Mumbai, and 10 key informant interviews with community leaders and health care providers. Participants' mean age was 26.1 years (SD 4.8); 62% completed secondary education, and 42% engaged in sex work. No focus group participants had heard of PrEP, but once explained, most reported they would likely use it. PrEP was alternately perceived as a 'back-up plan', a condom substitute, or a burden with concurrent condom use. Facilitators were potential for covert use, sex without condoms, and anxiety-less sex. Potential barriers emerged around stigma associated with PrEP use, fear of disclosures to one's family, wife, or male steady partner, and being labeled as HIV-positive or promiscuous by peers. Preferences emerged for intermittent rather than daily PrEP use, injectable PrEP, and free or subsidized access through community organizations or government hospitals. Key informants expressed additional concerns about risk...Continue Reading

References

Aug 10, 2007·AIDS Education and Prevention : Official Publication of the International Society for AIDS Education·Venkatesan ChakrapaniFredrick Melwin
May 20, 2008·Culture, Health & Sexuality·Venkatesan ChakrapaniMurali Shunmugam
Nov 26, 2010·The New England Journal of Medicine·Robert M GrantUNKNOWN iPrEx Study Team
Mar 1, 2012·International Journal of STD & AIDS·S McCormackUNKNOWN British Association for Sexual Health and HIV
Sep 14, 2012·Science Translational Medicine·Peter L AndersonUNKNOWN iPrEx Study Team
Sep 1, 2011·SAHARA J : Journal of Social Aspects of HIV/AIDS Research Alliance·Shalini Bharat
Feb 22, 2013·AIDS Patient Care and STDs·Yan ZhangAilong Huang
Jun 21, 2013·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Jeremy Sugarman, Kenneth H Mayer
Jun 21, 2013·Culture, Health & Sexuality·Venkatesan ChakrapaniAshok Row Kavi
Feb 5, 2014·Lancet·Tony Kirby, Michelle Thornber-Dunwell
Jun 14, 2014·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·K Rivet Amico, Michael J Stirratt

❮ Previous
Next ❯

Citations

Apr 29, 2016·The Indian Journal of Medical Research·Kenneth H MayerBeena Thomas
Nov 20, 2016·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Susanne Doblecki-LewisMichael A Kolber
Nov 23, 2017·Cadernos de saúde pública·Artur Acelino Francisco Luz Nunes Queiroz, Alvaro Francisco Lopes de Sousa
Dec 1, 2017·AIDS Patient Care and STDs·Daniel GraceDarrell H S Tan
Jan 13, 2018·Archives of Sexual Behavior·Kristen UnderhillKenneth H Mayer
Jan 18, 2020·AIDS Patient Care and STDs·Venkatesan ChakrapaniPeter A Newman
Mar 29, 2019·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Pooyan KazemianKenneth A Freedberg
Mar 28, 2019·AIDS Education and Prevention : Official Publication of the International Society for AIDS Education·Chen Seong WongMark I Chen
Apr 11, 2019·AIDS Education and Prevention : Official Publication of the International Society for AIDS Education·Deng-Min Chuang, Peter A Newman
Feb 27, 2021·Sexual Health·Rena JanamnuaysookReshmie Ashmanie Ramautarsing

❮ Previous
Next ❯

Software Mentioned

iPrEx

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.